Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized-Withdrawal Study of Xyrem in Pediatric Narcolepsy with Cataplexy
2014-001389-93Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in narcolepsy type 1 (NT1) comparing Xyrem arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy endpoints. Started Dec 2014; status: completed.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on 2014-001389-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001389-93.